Cargando…

Interaction of a traditional Chinese Medicine (PHY906) and CPT-11 on the inflammatory process in the tumor microenvironment

BACKGROUND -: Traditional Chinese Medicine (TCM) has been used for thousands of years to treat or prevent diseases, including cancer. Good manufacturing practices (GMP) and sophisticated product analysis (PhytomicsQC) to ensure consistency are now available allowing the assessment of its utility. Po...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ena, Bussom, Scott, Chen, Jinguo, Quinn, Courtney, Bedognetti, Davide, Lam, Wing, Guan, Fulan, Jiang, Zaoli, Mark, Yichao, Zhao, Yingdong, Stroncek, David F, White, Jeffrey, Marincola, Francesco M, Cheng, Yung-Chi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117677/ https://www.ncbi.nlm.nih.gov/pubmed/21569348 http://dx.doi.org/10.1186/1755-8794-4-38

Ejemplares similares

PHY906(KD018), an adjuvant based on a 1800-year-old Chinese medicine, enhanced the anti-tumor activity of Sorafenib by changing the tumor microenvironment
por: Lam, Wing, et al.
Publicado: (2015)

Mechanism Based Quality Control (MBQC) of Herbal Products: A Case Study YIV-906 (PHY906)
por: Lam, Wing, et al.
Publicado: (2018)

The number of intestinal bacteria is not critical for the enhancement of antitumor activity and reduction of intestinal toxicity of irinotecan by the Chinese herbal medicine PHY906 (KD018)
por: Lam, Wing, et al.
Publicado: (2014)

YIV-906 potentiated anti-PD1 action against hepatocellular carcinoma by enhancing adaptive and innate immunity in the tumor microenvironment
por: Yang, Xiaochen, et al.
Publicado: (2021)

WGCNA reveals key gene modules regulated by the combined treatment of colon cancer with PHY906 and CPT11
por: Xing, Shuqin, et al.
Publicado: (2020)

The Significant Pathways and Genes Underlying the Colon Cancer Treatment by the Traditional Chinese Medicine PHY906
por: Su, Ziyuan, et al.
Publicado: (2017)

A comprehensive platform for quality control of botanical drugs (PhytomicsQC): a case study of Huangqin Tang (HQT) and PHY906
por: Tilton, Robert, et al.
Publicado: (2010)

A Phase II Clinical Trial on the Combination Therapy of PHY906 Plus Capecitabine in Hepatocellular Carcinoma
por: Changou, Chun A., et al.
Publicado: (2020)

CP and CPT measurements at DA$\phi$NE
por: D'Ambrosio, G., et al.
Publicado: (1994)

Development of an asymmetric $\Phi$ factory for precision CPT tests
por: Cline, David B
Publicado: (1997)

Interferon-γ and Tumor Necrosis Factor-α Polarize Bone Marrow Stromal Cells Uniformly to a Th1 Phenotype
por: Jin, Ping, et al.
Publicado: (2016)

Workshop on Testing CPT and Studying CP Violation at a $\phi$ Factory
por: Cline, David B
Publicado: (1990)

YIV-906 enhances nuclear factor of activated T-cells (NFAT) activity of T cells and promotes immune checkpoint blockade antibody action and CAR T-cell activity
por: Lam, Wing, et al.
Publicado: (2023)

YIV-818-A: a novel therapeutic agent in prostate cancer management through androgen receptor downregulation, glucocorticoid receptor inhibition, epigenetic regulation, and enhancement of apalutamide, darolutamide, and enzalutamide efficacy
por: Lam, Wing, et al.
Publicado: (2023)

Measurement of the phases $\phi_{+-}$ and $\phi_{00}$ : a precise test of CPT symmetry in the $K^{0}- \overline{K}^{0}$ system
por: Augé, E
Publicado: (1994)

Measurement of the phases $\phi_{\pm}$ and $\phi_{00}$ of the CP-violating amplitudes in $K^{0}\rightarrow 2\pi$ decay and test of CPT invariance
por: Zech, G
Publicado: (1990)

The stable traits of melanoma genetics: an alternate approach to target discovery
por: Spivey, Tara L, et al.
Publicado: (2012)

Meta-analysis and metagenes: CXCL-13-driven signature as a robust marker of intratumoral immune response and predictor of breast cancer chemotherapeutic outcome
por: Bedognetti, Davide, et al.
Publicado: (2014)

MicroRNA and gene expression patterns in the differentiation of human embryonic stem cells
por: Ren, Jiaqiang, et al.
Publicado: (2009)

Carpal Tunnel Syndrome: The Role of Occupational Factors Among 906 Workers
por: Ghasemi, Mohammad, et al.
Publicado: (2012)

Fantasia in C minor, BWV906 Fifteen two-part inventions ; Fifteen three-part sinfonias (inventions) ; Chromatic fantasia and fugue : in D minor, BWV903 /
por: Bach, Johann Sebastian, 1685-1750
Publicado: (1994)

906 How Mandatory Public Reporting Undermines Infection Prevention: An Ethnographic Study
por: Szymczak, Julia E., et al.
Publicado: (2014)

SUN-906 To Function or Not to Function: A Rare Case of Metachronous Hormone Syndrome
por: Amine, Adele, et al.
Publicado: (2020)

Treatment of neuroblastoma and rhabdomyosarcoma using RGD-modified liposomal formulations of patupilone (EPO906)
por: Scherzinger-Laude, Karine, et al.
Publicado: (2013)

MON-906 MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A: Familiar Case Report
por: Sousa, Barbara K P, et al.
Publicado: (2020)

Evaluation of the pharmacokinetics of trazpiroben (TAK‐906) in the presence and absence of the proton pump inhibitor esomeprazole
por: Kaur Mukker, Jatinder, et al.
Publicado: (2022)

CPT and Superstring
por: Ellis, John R., et al.
Publicado: (1996)

Feasibility of recruiting high-risk women in the US for HIV vaccine efficacy trials (HVTN 906)
por: Koblin, B, et al.
Publicado: (2012)

Operación y mantenimiento de la impresora MT 906 con proceso electrofotográfico láser /
por: Pérez Ramírez, Ángela
Publicado: (1994)

Development and Characterization of 1,906 EST-SSR Markers from Unigenes in Jute (Corchorus spp.)
por: Zhang, Liwu, et al.
Publicado: (2015)

906. Surgical Site Infections in Children with Beta-Lactam Allergy: A Matched Cohort Study
por: Huang, Felicia Scaggs, et al.
Publicado: (2020)

Molecular signatures of maturing dendritic cells: implications for testing the quality of dendritic cell therapies
por: Jin, Ping, et al.
Publicado: (2010)

A strategy for detection of known and unknown SNP using a minimum number of oligonucleotides applicable in the clinical settings
por: Wang, Ena, et al.
Publicado: (2003)

CP, T and CPT at CPLEAR
por: Filipcic, Andrej, et al.
Publicado: (2001)

Tests of CPT with CPLEAR
por: Mikuz, M
Publicado: (2000)

Tests of CPT with CPLEAR
por: Adler, R, et al.
Publicado: (1996)

Test of CPT with antiprotons
por: Poth, Helmut
Publicado: (1978)

Cold antihydrogen and CPT
por: Gabrielse, G, et al.
Publicado: (2002)

Mechanism for CPT violation
por: Klinkhamer, F R
Publicado: (2001)

T and CPT in B-Factories
por: Bernabeu, J, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_uo6cafcrt4omucq3fvjc8g89b1